Dr Reddy's Laboratories Q3 net dips 29% at Rs 363 cr
Quotes

Dr Reddy's Laboratories Q3 net dips 29% at Rs 363 cr

Last Updated: Thursday, February 14, 2013, 14:29
 
 Comment 0
 
Dr Reddy's Laboratories Q3 net dips 29% at Rs 363 cr
New Delhi: Drug major Dr Reddy's Laboratories on Thursday reported 29.17 percent decline in its consolidated net profit at Rs 363.31 crore for the third quarter ended December 31, 2012.

The company had posted a net profit of Rs 512.96 crore in the same period of previous fiscal, Dr Reddy's Laboratories said in a filing to the BSE.

The Hyderabad-based firm's consolidated net income from sales and services, however, rose to Rs 2,865.16 crore in the third quarter, compared to Rs 2,769.19 crore in the same period of 2011-12 fiscal.

On a standalone basis, the company's net profit rose over three-fold to Rs 346.64 crore for the third quarter, against Rs 108.03 crore in the same period of previous fiscal.

Shares of Dr Reddy's Laboratories were trading at Rs 1,884.50 apiece on the BSE in late afternoon trade, down 1.11 percent from its previous close.

PTI



First Published: Thursday, February 14, 2013, 14:29


Comments


comments powered by Disqus
BMW-X3
BMW-X3
Forbes Best Places for Biz 2014
Forbes Best Places for Biz 2014
Hyundai Elite i20
Hyundai Elite i20
Honda Mobilio MPV
Honda Mobilio MPV
Tata Zest first drive review: In pics
Tata Zest first drive review: In pics

Web Wrap
Contact Us : Privacy Policy : Legal Disclaimer
Copyright © Zee Media Corporation Ltd. All rights reserved